3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide
C105H75N31O12S2 — CID 158414327
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide
3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide (PubChem CID 158414327) has the molecular formula C105H75N31O12S2 and a molecular weight of 2027.09 g/mol. Its IUPAC name is 3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide.
Molecular Properties
| Compound Name | 3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide |
|---|---|
| PubChem CID | 158414327 |
| Molecular Formula | C105H75N31O12S2 |
| Molecular Weight | 2027.09 g/mol |
| Exact Mass | 2025.57 |
| IUPAC Name | 3-hydroxy-4-[(3-methyl-1,2,4-oxadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-phenylnaphthalene-2-carboxamide;3-hydroxy-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-N-pyrimidin-2-ylnaphthalene-2-carboxamide;3-hydroxy-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)diazenyl]-N-pyridin-4-ylnaphthalene-2-carboxamide;3-hydroxy-N-phenyl-4-[(1-pyrimidin-2-yl-1,2,4-triazol-3-yl)diazenyl]naphthalene-2-carboxamide |
| SMILES | Cc1noc(/N=N/c2c(O)c(C(=O)Nc3ccccc3)cc3ccccc23)n1.Cc1nsc(/N=N/c2c(O)c(C(=O)Nc3ccccc3)cc3ccccc23)n1.Cc1nsc(/N=N/c2c(O)c(C(=O)Nc3ncccn3)cc3ccccc23)n1.O=C(Nc1ccccc1)c1cc2ccccc2c(/N=N/c2ncn(-c3ncccn3)n2)c1O.O=C(Nc1ccncc1)c1cc2ccccc2c(/N=N/c2nnc(-c3ccccc3)o2)c1O |
| InChI | InChI=1S/C24H16N6O3.C23H16N8O2.C20H15N5O3.C20H15N5O2S.C18H13N7O2S/c31-21-19(22(32)26-17-10-12-25-13-11-17)14-16-8-4-5-9-18(16)20(21)27-29-24-30-28-23(33-24)15-6-2-1-3-7-15;32-20-18(21(33)27-16-8-2-1-3-9-16)13-15-7-4-5-10-17(15)19(20)28-29-22-26-14-31(30-22)23-24-11-6-12-25-23;2*1-12-21-20(28-25-12)24-23-17-15-10-6-5-7-13(15)11-16(18(17)26)19(27)22-14-8-3-2-4-9-14;1-10-21-18(28-25-10)24-23-14-12-6-3-2-5-11(12)9-13(15(14)26)16(27)22-17-19-7-4-8-20-17/h1-14,31H,(H,25,26,32);1-14,32H,(H,27,33);2*2-11,26H,1H3,(H,22,27);2-9,26H,1H3,(H,19,20,22,27)/b29-27+;29-28+;3*24-23+ |
| InChIKey | GZRUUFMWRGVTQW-MSJOYWSQSA-N |
| XLogP | 24.68 |
| TPSA | 594.81 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2027.09 |
| LogP ≤ 5 | 24.68 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 40 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158414327 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.